Iran talks in focus; Sandisk, Block earnings - what’s moving markets

U.S. stock index futures were mixed (Dow +0.2%, S&P 500 +0.2%, Nasdaq 100 -0.1%) as markets digested Middle East shipping-route developments tied to Iran/Strait of Hormuz talks and a slowing earnings/news flow. In company updates, Sandisk guided fiscal Q1 2027 revenue to $10.3B–$10.8B (vs $10.62B consensus) with EPS $44.00–$46.00 (vs $44.21), sending shares down ~2% after-hours, while Block beat quarterly results and raised full-year adjusted profit outlook and Moderna’s mFLUSIVA received FDA approval for adults 50+ after a 40,805-patient Phase 3 trial, lifting shares in extended hours.

Analysis

A credible easing in Strait of Hormuz risk is a near-term win for cyclicals that are input-cost sensitive more than for the market as a whole. Transports, airlines, chemicals, and consumer discretionary should get an immediate multiple lift from lower energy volatility, while energy equities lose the risk premium first; the second-order effect is that even a partial tolling regime would likely keep shipping insurance and tanker economics structurally tighter than pre-conflict norms. The contrarian read is that "peace" may normalize headline volatility without fully restoring frictionless flows, so the market may be over-discounting the downside to oil and underpricing a new, bureaucratic cost layer.

The AMD headline is less about one customer and more about a broader signal that merchant silicon can be displaced when internal design cycles mature. That matters because the market has been paying for a persistent AI capex super-cycle; any proof that large buyers can pause or redesign around third-party chips can compress the multiple across AMD and the broader semi complex (SMH/SOXX), even if unit economics stay healthy. SNDK’s in-line guide after a very strong run suggests the memory upcycle is intact but the easy rerating phase is probably over unless spot pricing or backlog inflects again.

Moderna’s approval is valuable as platform validation, but the cash flow payoff is deferred and still depends on real-world uptake in a crowded flu market, so this is more of a 6-18 month optionality story than a near-term fundamentals change. Block’s raised outlook is similarly more about downside stabilization than a new growth leg; the market will want evidence of Cash App monetization quality and credit discipline before paying a higher multiple. Friday’s jobs report is the key cross-asset catalyst: a hot wage print would reinforce the rotation out of long-duration growth, while a softer labor number could cushion semis and biotech.

Key Decisions for Investors

• Long IYT / short XLE for 1-3 months: express lower oil risk premium and cheaper fuel as a transport margin tailwind; take profits if Brent re-accelerates on stalled Iran talks or the strait fee regime proves more punitive than expected.
• Short AMD on strength or buy 4-8 week puts: treat the customer-loss headline as a sentiment warning for AI capex durability, not a revenue disaster; cover if management/earnings commentary shows replacement demand from other hyperscalers or if SMH recoups the semiconductor tape.
• Avoid chasing SNDK after the gap; if already long, trim 25-50% into strength and wait for the next guide revision or spot pricing data before re-adding. The risk/reward worsens when a very good quarter is met with only an in-line outlook.
• Initiate a small MRNA call-spread position only on a pullback, targeting the 2026 respiratory season rather than near-term revenue. Falsifier: if early retailer/ordering data do not improve by fall, the approval remains a headline event, not a P&L driver.
• No fresh long in Block on this print; use it as a watch item for Cash App gross-profit reacceleration and BNPL credit metrics. If those metrics do not improve next quarter, the raised guide is likely a ceiling rather than a re-rating catalyst.